#GDR - Plenty churn taking place - volumes have been better but nothing amazing - that being said more and more stock has been entering stickier hands - accounting for the overhang we are holding up very well and it goes to show buyers appetite is there. Major move incoming imo.

#GDR -
https://abs.twimg.com/emoji/v2/... draggable="false" alt="🔹" title="Kleine blaue Raute" aria-label="Emoji: Kleine blaue Raute">Contracts following SA Approval
https://abs.twimg.com/emoji/v2/... draggable="false" alt="🔹" title="Kleine blaue Raute" aria-label="Emoji: Kleine blaue Raute">WHO/FDA EUA Approvals
https://abs.twimg.com/emoji/v2/... draggable="false" alt="🔹" title="Kleine blaue Raute" aria-label="Emoji: Kleine blaue Raute">India update re Divoc and approval
https://abs.twimg.com/emoji/v2/... draggable="false" alt="🔷" title="Große blaue Raute" aria-label="Emoji: Große blaue Raute">Beckman Coulter update (the big one)
All yet to come & the MCAP sits at £60m odd - you just have to look at peers to get an idea of where this is headed. £5 target.

#GDR - This month will see us undergo a spectacular rerate if Mr Reeds enthusiasm is anything to go by ‘US Go Live’ this month.

#GDR - Have a current production capacity of 10k tests per hour - these tests are being automated & validated by Beckman Coulter as per RNS - Beckman contracted by HSS to provide tests to 10 sites to upscale upto 100k tests per day across the US. This is potentially the deal imo.

#GDR - If contracted for just 100k tests a day at £8-£10 (so let’s say £9 a test) with 60% profit margin = £540k profit per day / £3.78m per week / £15.12m per month / £181m odd a year PROFIT. MCAP £60m odd - scope for upside is crazy .

#GDR - Chart courtesy @Justsharesonaim who nails em bang on - Top of the shop 586p. https://abs.twimg.com/emoji/v2/... draggable="false" alt="💥" title="Symbol für eine Kollision" aria-label="Emoji: Symbol für eine Kollision">